[News Brief] GSK Receives Japanese Approval for Depemokimab
Japan’s Ministry of Health, Labour and Welfare has approved GSK’s depemokimab (Exdensur) as an add-on treatment for certain types of…
Japan’s Ministry of Health, Labour and Welfare has approved GSK’s depemokimab (Exdensur) as an add-on treatment for certain types of…
The Health Sciences Authority (HSA) of Singapore and the Indonesian Food and Drug Authority (Indonesian FDA) have signed a Memorandum…
Sanofi has announced that the US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics licence…
Takeda has published results from its Phase 3 clinical trials for Zasocitinib, an oral treatment for moderate-to-severe plaque psoriasis. This…
Lunit has announced a collaboration with Daiichi Sankyo to advance research in AI‑driven biomarker discovery and translational oncology. This summary…
Cinclus Pharma Holding AB’s drug linaprazan glurate has been included in China’s 2025 National Reimbursement Drug List (NRDL) ahead of…
Gushengtang has introduced 10 AI avatars modelled on renowned Traditional Chinese Medicine (TCM) experts as part of its ongoing integration…
The University of Florida’s Centre for Natural Products, Drug Discovery and Development (CNPD3) has formed a trilateral research partnership with…
A.P. Moller – Maersk has opened its first own‑licensed bonded warehouse in Northern Vietnam, located at SLP Park, Nam Dinh…
ChemLex, an AI-for-science startup, has raised USD 45 million in seed funding to launch a self-driving laboratory for drug discovery…